Welcome to our dedicated page for Brighthouse SEC filings (Ticker: BHFAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Brighthouse's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Brighthouse's regulatory disclosures and financial reporting.
Brighthouse Financial, Inc. director Paul M. Wetzel reported equity compensation and related movements in company stock. He exercised 2,837 Restricted Stock Units (RSUs) into the same number of shares of common stock on June 2, 2026, reflecting an option-like conversion rather than an open-market purchase. Following this exercise, his direct common stock holdings increased to 23,663 shares. On the same date, he received a new grant of 2,651 RSUs as an award for service as a Board member under Brighthouse Financial’s 2017 Non-Management Director Stock Compensation Plan. These RSUs each represent the contingent right to receive one share of common stock and will vest on the earlier of the first anniversary of the grant or the 2027 annual stockholders meeting. The filing also shows 9 shares of common stock held indirectly through his spouse.
Brighthouse Financial, Inc. director Paul M. Wetzel reported equity compensation and related movements in company stock. He exercised 2,837 Restricted Stock Units (RSUs) into the same number of shares of common stock on June 2, 2026, reflecting an option-like conversion rather than an open-market purchase. Following this exercise, his direct common stock holdings increased to 23,663 shares. On the same date, he received a new grant of 2,651 RSUs as an award for service as a Board member under Brighthouse Financial’s 2017 Non-Management Director Stock Compensation Plan. These RSUs each represent the contingent right to receive one share of common stock and will vest on the earlier of the first anniversary of the grant or the 2027 annual stockholders meeting. The filing also shows 9 shares of common stock held indirectly through his spouse.
Brighthouse Financial director Carol Juel reported equity compensation and deferral activity involving company stock. On June 2, 2026, she received a grant of 2,651 Restricted Stock Units (RSUs) for service on the board under the 2017 Non-Management Director Stock Compensation Plan. These RSUs will vest on the earlier of the first anniversary of the grant date or the 2027 annual meeting, with vested shares deferred under the company’s deferred compensation plan. On the same date, 2,837 previously granted RSUs vested at the 2026 annual meeting and were converted into 2,837 deferred RSUs, increasing her deferred RSU balance to 10,390 units. These transactions are compensation awards and conversions, with no open-market purchases or sales.
Brighthouse Financial director Carol Juel reported equity compensation and deferral activity involving company stock. On June 2, 2026, she received a grant of 2,651 Restricted Stock Units (RSUs) for service on the board under the 2017 Non-Management Director Stock Compensation Plan. These RSUs will vest on the earlier of the first anniversary of the grant date or the 2027 annual meeting, with vested shares deferred under the company’s deferred compensation plan. On the same date, 2,837 previously granted RSUs vested at the 2026 annual meeting and were converted into 2,837 deferred RSUs, increasing her deferred RSU balance to 10,390 units. These transactions are compensation awards and conversions, with no open-market purchases or sales.
Brighthouse Financial director Stephen C. Hooley reported stock-based compensation and deferral activity. He received a grant of 2,651 Restricted Stock Units (RSUs) for service on the board, each representing one share of Brighthouse Financial common stock.
These new RSUs will vest on the earlier of the first anniversary of the grant date or the 2027 annual meeting of stockholders and will then be deferred under the company’s deferred compensation plan. Separately, RSUs that vested on the date of the 2026 annual meeting were converted into 2,837 deferred RSUs, which will be settled in shares or cash after his board service ends or according to his deferral election. All transactions are compensation-related grants and conversions, with no open-market purchases or sales.
Brighthouse Financial director Stephen C. Hooley reported stock-based compensation and deferral activity. He received a grant of 2,651 Restricted Stock Units (RSUs) for service on the board, each representing one share of Brighthouse Financial common stock.
These new RSUs will vest on the earlier of the first anniversary of the grant date or the 2027 annual meeting of stockholders and will then be deferred under the company’s deferred compensation plan. Separately, RSUs that vested on the date of the 2026 annual meeting were converted into 2,837 deferred RSUs, which will be settled in shares or cash after his board service ends or according to his deferral election. All transactions are compensation-related grants and conversions, with no open-market purchases or sales.
Brighthouse Financial, Inc. director Michael J. Inserra reported equity compensation-related transactions in company stock. On 2026-06-02, he exercised previously granted restricted stock units and deferred restricted stock units to acquire 1,418 shares of Common Stock at a stated price of $0.00 per share, reflecting the conversion of vested awards rather than an open-market purchase.
Inserra also received a new grant of 2,651 Restricted Stock Units for service on the Board under the company’s 2017 Non-Management Director Stock Compensation Plan. The filing shows 4,256 derivative units were exercised or converted in total, and after these transactions he directly holds 9,116 shares of Common Stock. He also holds 3,618 Deferred Restricted Stock Units, which represent rights to receive Brighthouse common stock or equivalent cash in the future in line with his deferral elections and service as a director.
Brighthouse Financial, Inc. director Michael J. Inserra reported equity compensation-related transactions in company stock. On 2026-06-02, he exercised previously granted restricted stock units and deferred restricted stock units to acquire 1,418 shares of Common Stock at a stated price of $0.00 per share, reflecting the conversion of vested awards rather than an open-market purchase.
Inserra also received a new grant of 2,651 Restricted Stock Units for service on the Board under the company’s 2017 Non-Management Director Stock Compensation Plan. The filing shows 4,256 derivative units were exercised or converted in total, and after these transactions he directly holds 9,116 shares of Common Stock. He also holds 3,618 Deferred Restricted Stock Units, which represent rights to receive Brighthouse common stock or equivalent cash in the future in line with his deferral elections and service as a director.
Brighthouse Financial, Inc. director Eileen A. Mallesch reported equity compensation and related conversions, not open‑market trades. On 2026-06-02, she received an award of 2,651 Restricted Stock Units for service as a Board member under the Brighthouse Financial, Inc. 2017 Non-Management Director Stock Compensation Plan. These RSUs will vest on the earlier of the first anniversary of the grant date or the date of the 2027 annual meeting of stockholders and each unit represents the right to receive one share of Brighthouse Financial common stock.
On the same date, 2,837 RSUs that had vested at the 2026 annual meeting were exercised and deferred into Deferred Restricted Stock Units under the Brighthouse Services, LLC Deferred Compensation Plan for Non-Management Directors. Each deferred unit represents the right to receive one share of common stock or a cash amount equal to one share’s value, with payout timing based on the director’s deferral election or, if earlier, upon termination of Board service. Following these actions, Mallesch held 20,820 shares of common stock directly.
Brighthouse Financial, Inc. director Eileen A. Mallesch reported equity compensation and related conversions, not open‑market trades. On 2026-06-02, she received an award of 2,651 Restricted Stock Units for service as a Board member under the Brighthouse Financial, Inc. 2017 Non-Management Director Stock Compensation Plan. These RSUs will vest on the earlier of the first anniversary of the grant date or the date of the 2027 annual meeting of stockholders and each unit represents the right to receive one share of Brighthouse Financial common stock.
On the same date, 2,837 RSUs that had vested at the 2026 annual meeting were exercised and deferred into Deferred Restricted Stock Units under the Brighthouse Services, LLC Deferred Compensation Plan for Non-Management Directors. Each deferred unit represents the right to receive one share of common stock or a cash amount equal to one share’s value, with payout timing based on the director’s deferral election or, if earlier, upon termination of Board service. Following these actions, Mallesch held 20,820 shares of common stock directly.
Brighthouse Financial director C. Edward Chaplin reported equity compensation changes. On June 2, 2026, he acquired 4,556 shares of common stock through the exercise of previously granted Restricted Stock Units, bringing his direct common stock holdings to 54,454 shares.
On the same date, he received a new grant of 4,257 Restricted Stock Units for service as a Board member and independent Chairman, each RSU representing one share of common stock. These RSUs will vest on the earlier of the first anniversary of the grant date or the date of the 2027 annual meeting of stockholders.
Brighthouse Financial director C. Edward Chaplin reported equity compensation changes. On June 2, 2026, he acquired 4,556 shares of common stock through the exercise of previously granted Restricted Stock Units, bringing his direct common stock holdings to 54,454 shares.
On the same date, he received a new grant of 4,257 Restricted Stock Units for service as a Board member and independent Chairman, each RSU representing one share of common stock. These RSUs will vest on the earlier of the first anniversary of the grant date or the date of the 2027 annual meeting of stockholders.
Brighthouse Financial director Lizabeth H. Zlatkus reported routine equity compensation activity. She exercised 2,837 previously granted Restricted Stock Units (RSUs), receiving the same number of Brighthouse common shares, and now directly holds 7,234 common shares. She also received a new award of 2,651 RSUs for Board service, which will convert one-for-one into common stock upon vesting.
Brighthouse Financial director Lizabeth H. Zlatkus reported routine equity compensation activity. She exercised 2,837 previously granted Restricted Stock Units (RSUs), receiving the same number of Brighthouse common shares, and now directly holds 7,234 common shares. She also received a new award of 2,651 RSUs for Board service, which will convert one-for-one into common stock upon vesting.
Brighthouse Financial director Diane E. Offereins exercised 2,837 Restricted Stock Units into the same number of common shares on June 2, 2026, and received a new award of 2,651 RSUs for board service. She now directly holds 28,634 common shares plus 2,651 RSUs subject to future vesting.
Brighthouse Financial director Diane E. Offereins exercised 2,837 Restricted Stock Units into the same number of common shares on June 2, 2026, and received a new award of 2,651 RSUs for board service. She now directly holds 28,634 common shares plus 2,651 RSUs subject to future vesting.
Brighthouse Financial, Inc. held its 2026 Annual Meeting of Stockholders on June 2, 2026, where stockholders voted on three proposals. All nine director nominees listed in the company’s proxy statement were elected to one-year terms ending at the 2027 Annual Meeting, each receiving over 37.4 million votes in favor with relatively few votes against or abstentions.
Stockholders also ratified Deloitte & Touche LLP as the company’s independent registered public accounting firm for fiscal year 2026, with 43,086,381 votes for, 147,967 against and 80,592 abstentions. In addition, stockholders approved the advisory Say-on-Pay resolution on executive compensation, with 37,075,125 votes for, 545,676 against and 177,414 abstentions, alongside 5,516,725 broker non-votes.
Brighthouse Financial, Inc. held its 2026 Annual Meeting of Stockholders on June 2, 2026, where stockholders voted on three proposals. All nine director nominees listed in the company’s proxy statement were elected to one-year terms ending at the 2027 Annual Meeting, each receiving over 37.4 million votes in favor with relatively few votes against or abstentions.
Stockholders also ratified Deloitte & Touche LLP as the company’s independent registered public accounting firm for fiscal year 2026, with 43,086,381 votes for, 147,967 against and 80,592 abstentions. In addition, stockholders approved the advisory Say-on-Pay resolution on executive compensation, with 37,075,125 votes for, 545,676 against and 177,414 abstentions, alongside 5,516,725 broker non-votes.
Brighthouse Financial, Inc. reported a sharp loss for the three months ended March 31, 2026 while preparing to be acquired. The company has agreed to a cash merger under which each common share will be converted into $70.00 in cash at closing.
For the quarter, total revenues were $1.53 billion, down from $2.39 billion a year earlier, mainly because net derivative results swung from a gain of $311 million to a loss of $509 million. The change in market risk benefits expense also remained large at $748 million.
Brighthouse posted a net loss attributable to the company of $766 million, compared with a $268 million loss in the prior-year period. Net loss available to common shareholders widened to $792 million, or $(13.82) per diluted share, versus $(5.04) per share last year. Stockholders’ equity fell to $5.56 billion at March 31, 2026 from $6.77 billion at year-end 2025, reflecting the loss and lower accumulated other comprehensive income.
Brighthouse Financial, Inc. reported a sharp loss for the three months ended March 31, 2026 while preparing to be acquired. The company has agreed to a cash merger under which each common share will be converted into $70.00 in cash at closing.
For the quarter, total revenues were $1.53 billion, down from $2.39 billion a year earlier, mainly because net derivative results swung from a gain of $311 million to a loss of $509 million. The change in market risk benefits expense also remained large at $748 million.
Brighthouse posted a net loss attributable to the company of $766 million, compared with a $268 million loss in the prior-year period. Net loss available to common shareholders widened to $792 million, or $(13.82) per diluted share, versus $(5.04) per share last year. Stockholders’ equity fell to $5.56 billion at March 31, 2026 from $6.77 billion at year-end 2025, reflecting the loss and lower accumulated other comprehensive income.